NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 192)
Posted On: 12/20/2017 6:32:45 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Major Software Enhancement for Barocycler 2320EXTREME Instrument
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at one of the world’s largest biopharmaceutical firms, the software upgrade makes the company’s instrument one of the few Good Manufacturing Practices-compliant, computer-controlled sample preparation systems available on the worldwide life sciences market today. “In essence, the 2320EXT offers rapid and reproducible sample preparation for the characterization and quality control of biotherapeutics, now coupled with the assurance of GMP ready software control, achieving a pivotally important requirement for the biopharmaceutical industry,” Dr. Alexander Lazarev, PBIO’s vice president of research and development, stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced the release of extensively redesigned software for its Barocycler 2320EXTREME instrument. The result of a year-long collaborative effort between the PBIO team and customers at one of the world’s largest biopharmaceutical firms, the software upgrade makes the company’s instrument one of the few Good Manufacturing Practices-compliant, computer-controlled sample preparation systems available on the worldwide life sciences market today. “In essence, the 2320EXT offers rapid and reproducible sample preparation for the characterization and quality control of biotherapeutics, now coupled with the assurance of GMP ready software control, achieving a pivotally important requirement for the biopharmaceutical industry,” Dr. Alexander Lazarev, PBIO’s vice president of research and development, stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼